
CorMedix CRMD
$ 12.55
2.95%
Quarterly report 2025-Q3
added 11-12-2025
CorMedix Operating Cycle 2011-2025 | CRMD
Annual Operating Cycle CorMedix
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 127 | 226 | 261 | 331 | 403 | 1.96 K | 186 | 980 | 534 | 572 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.96 K | 127 | 558 |
Quarterly Operating Cycle CorMedix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 321 | 470 | 433 | - | 836 | - | - | - | - | - | - | - | 61.8 | 602 | 457 | - | 224 | 760 | 194 | - | 167 | 702 | 455 | - | 391 | 1.46 K | 157 | - | 128 | 1.29 K | 1.78 K | - | 928 | 3.05 K | 459 | -166 K | 381 | 148 | 854 | 664 K | -423 K | -96.8 K | -1.67 M | - | -1.04 K | -591 | 2.75 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 664 K | -1.67 M | -50.8 K |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
12 | $ 1.15 | -1.71 % | $ 6.27 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 4.78 | -0.31 % | $ 793 M | ||
|
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.03 | -0.49 % | $ 234 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Aptevo Therapeutics
APVO
|
191 | $ 0.6 | -35.8 % | $ 166 K | ||
|
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Berkeley Lights
BLI
|
349 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
195 | $ 27.09 | 1.04 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
28.8 | - | -10.95 % | $ 876 K | ||
|
Anika Therapeutics
ANIK
|
325 | $ 9.6 | 1.27 % | $ 141 M | ||
|
bluebird bio
BLUE
|
127 | - | - | $ 546 M | ||
|
Zai Lab Limited
ZLAB
|
171 | $ 18.4 | -0.97 % | $ 18.2 B | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 12.33 | -0.29 % | $ 812 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
116 | $ 584.81 | -1.07 % | $ 44.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
360 | $ 2.44 | -3.56 % | $ 15.3 M | ||
|
AstraZeneca PLC
AZN
|
206 | $ 92.79 | 0.37 % | $ 96.9 B | ||
|
ChromaDex Corporation
CDXC
|
114 | - | -0.88 % | $ 598 M | ||
|
Certara
CERT
|
88.6 | $ 8.9 | -0.17 % | $ 1.43 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K |